Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Prokidney (PROK) Net Income towards Common Stockholders (2022 - 2025)

Prokidney (PROK) has disclosed Net Income towards Common Stockholders for 4 consecutive years, with -$40.9 million as the latest value for Q4 2025.

  • Quarterly Net Income towards Common Stockholders rose 15.74% to -$40.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$151.6 million through Dec 2025, up 7.18% year-over-year, with the annual reading at -$69.0 million for FY2025, 12.75% down from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was -$40.9 million at Prokidney, down from -$35.8 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was -$14.4 million in Q4 2022, with the low at -$67.5 million in Q1 2022.
  • Average Net Income towards Common Stockholders over 4 years is -$36.8 million, with a median of -$36.9 million recorded in 2023.
  • The sharpest move saw Net Income towards Common Stockholders skyrocketed 45.31% in 2023, then crashed 123.18% in 2024.
  • Over 4 years, Net Income towards Common Stockholders stood at -$14.4 million in 2022, then crashed by 50.86% to -$21.7 million in 2023, then tumbled by 123.18% to -$48.5 million in 2024, then increased by 15.74% to -$40.9 million in 2025.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at -$40.9 million, -$35.8 million, and -$37.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.